Literature DB >> 33506061

Protective Effects of Chicken Egg Yolk Immunoglobulins (IgYs) against Vibrio vulnificus Infections.

Ruizhao Cai1,2, Ning Liu1,2, Penghao Guo3, Kang Liao3, Mengzhi Li1,2, Junyou Zhu1,2, Shouyi Chen4, Lei Chen1,2, Bin Shu1,2, Shaohai Qi1,2.   

Abstract

Vibrio (V.) vulnificus infection is a rare disease whose death rates exceed 50% despite aggressive antibiotic treatment and surgical debridement. The aim of this study was to assess the ability of specific anti-V. vulnificus immunoglobulins Y (IgYs) for preventing and treating V. vulnificus infections. IgYs were produced by immunizing egg laying hens with inactivated whole cell bacteria. Peritoneal cytokines, blood's bacterial load, and survival curves were obtained from both prophylactic and therapeutic mouse models. The results showed that the specific IgYs (i) inhibited the growth of V. vulnificus in vitro, (ii) dramatically reduced the inflammatory response and blood's bacterial load, and (iii) improved the survival rate of V. vulnificus-infected mice. These results prove that anti-V. vulnificus IgYs can be markedly effective means for the prophylaxis and the therapy of V. vulnificus infections.
Copyright © 2021 Ruizhao Cai et al.

Entities:  

Year:  2021        PMID: 33506061      PMCID: PMC7808826          DOI: 10.1155/2021/6678513

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.818


  15 in total

1.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Chicken egg yolk antibody (IgY) as diagnostics and therapeutics in parasitic infections - A review.

Authors:  Diraviyam Thirumalai; Senthil Visaga Ambi; Ricardo S Vieira-Pires; Zhang Xiaoying; Saravanan Sekaran; Umamaheswari Krishnan
Journal:  Int J Biol Macromol       Date:  2019-06-17       Impact factor: 6.953

Review 3.  Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: A review.

Authors:  Sara Elmahdi; Ligia V DaSilva; Salina Parveen
Journal:  Food Microbiol       Date:  2016-02-22       Impact factor: 5.516

4.  Clinical features and treatment of patients with Vibrio vulnificus infection.

Authors:  Wei Yu; Xiaomin Shen; Hongying Pan; Tingting Xiao; Ping Shen; Yonghong Xiao
Journal:  Int J Infect Dis       Date:  2017-03-24       Impact factor: 3.623

5.  The Biology of Vibrio vulnificus.

Authors:  James D Oliver
Journal:  Microbiol Spectr       Date:  2015-06

6.  Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.

Authors:  Mahya Ranjbar; Bahador Behrouz; Fatemeh Norouzi; Seyed Latif Mousavi Gargari
Journal:  Mol Immunol       Date:  2019-10-18       Impact factor: 4.407

7.  Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein.

Authors:  Tae Hee Lee; Mi Hyun Kim; Chang-Seop Lee; Ju-Hyung Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Vaccine       Date:  2013-11-17       Impact factor: 3.641

8.  Additive function of Vibrio vulnificus MARTX(Vv) and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection.

Authors:  Hee-Gon Jeong; Karla J F Satchell
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 7.464

Review 9.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

Review 10.  Vibrio vulnificus infection: a persistent threat to public health.

Authors:  Na Ra Yun; Dong-Min Kim
Journal:  Korean J Intern Med       Date:  2018-06-15       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.